Rubraca (rucaparib): restriction of indication
About
This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.
Documents
Key facts
Medicine name |
Rubraca
|
Active substance |
rucaparib camsylate
|
Therapeutic area (MeSH) |
Ovarian Neoplasms
|
Procedure number |
EMEA/H/A-20/1518/C/4272/0033
|
Regulatory outcome |
Variation
|
DHPC type |
|
Referral name |
Rubraca
|
Human ATC code |
L01XX
|
Dissemination date |
12/08/2022
|